NCT00121030View on ClinicalTrials.gov

Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2002

Study Completion Date

December 31, 2003

Conditions
Gynecological MalignanciesGenital Neoplasms, FemaleAnemia
Interventions
DRUG

darbepoetin alfa

DRUG

recombinant human erythropoietin (rHuEPO)

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY